Navigation Links
New Approaches in Immunogenicity Assessment Using the New SQiDlite™ System: Case Study Analysis, New Life Science Webinar Hosted by Xtalks
Date:6/25/2013

Toronto, Canada (PRWEB) June 25, 2013

During this webinar, experts from SQI Diagnostics and Algorithme Pharma will discuss the use of a unique multiplexed immunoassay system to characterize Anti-Drug-Antibody (ADA) interaction.

A case study will be presented on Heparin-induced thrombocytopenia (HIT) antibodies developed in response to heparin, or its low molecular weight analogues using the SQI Diagnostics’ platform. This case study will illustrate the capabilities of the novel SQiDlite™ system in assessing the immunogenicity of a wide variety of biologic therapeutics which is required in safety and efficacy studies.

To learn more about the event, visit: http://xtalks.com/multiplexed-immunogenicity-assessment-sqidlite.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/6/prweb10842048.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Cost-Effective Approaches to Quality Distribution and Logistics for Temperature Sensitive Products
2. Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing”
3. ICD-10 Coding Knowledge Assessment Tool Released
4. Riordan Clinic Research Institute Has Developed and Patented a Process for the Assessment of the Energy Metabolism in Patients with Chronic Fatigue Syndrome
5. Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019
6. In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
7. Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
8. Addisons Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
9. CoreLab Partners, Medical Image Assessment Experts, Announces Its Entry Into the Early Alzheimers Imaging Market Space
10. BioInformatics LLC New Product Launch – RateMyProduct, a Quick Turnaround Product Assessment Tool for Life Science Suppliers
11. Research and Markets Announces Addition of the "Risk - Reward of Developing a Herceptin Biosimilar - A Thorough Assessment" Report to its Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , February 8, 2016 ... Private Limited, an innovation-driven oncology company developing next ... less toxic, today announced that chairman emeritus of ... invested in the company as part of the ... joining existing investors Navam Capital and Aarin Capital. ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... Directors. Todorow is the Executive Vice President for Corporate Services and the Chief ... Finance, Accounts Payable, Payroll, Billing Operations, Treasury, Managed Care Contracting, Supply Chain, and ...
(Date:2/8/2016)... ... February 08, 2016 , ... Information Management Services ( ... The upgrade represents a completely new technical foundation and is so significant it ... responsive design interface, significantly increased speed for search results, a streamlined layout and a ...
(Date:2/8/2016)... California (PRWEB) , ... February 08, 2016 , ... ... Intelligence (AI) and leading supplier of Semantic Graph Database technology, today announced the ... latest release of Cloudera Enterprise through the Cloudera Certified Technology Program ...
Breaking Biology Technology:
(Date:1/28/2016)... JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: SYNA ... results for its second quarter ended December 31, 2015. ... second quarter of fiscal 2016 increased 2 percent compared to the ... second quarter of fiscal 2016 was $35.0 million, or $0.93 per ... Non-GAAP net income for the first quarter of fiscal 2016 grew ...
(Date:1/22/2016)... January 22, 2016 ... addition of the  "Global Behavioral Biometric ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ... Behavioral Biometric Market 2016-2020"  report to ... and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ...
(Date:1/20/2016)... Minn. , Jan. 20, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... 2015. MedNet,s significant achievements are the result of the ... iMedNet eClinical , it,s comprehensive, easy-to-use ... --> --> Key MedNet growth achievements ...
Breaking Biology News(10 mins):